Docetaxel versus doxorubicin in patients with metastatic breast cancer whohave failed alkylating chemotherapy: A preliminary report of the randomized phase III trial
M. Aapro, Docetaxel versus doxorubicin in patients with metastatic breast cancer whohave failed alkylating chemotherapy: A preliminary report of the randomized phase III trial, SEMIN ONCOL, 25(5), 1998, pp. 7-11